181 related articles for article (PubMed ID: 30664827)
21. Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors.
Diedrich D; Hamacher A; Gertzen CG; Alves Avelar LA; Reiss GJ; Kurz T; Gohlke H; Kassack MU; Hansen FK
Chem Commun (Camb); 2016 Feb; 52(15):3219-22. PubMed ID: 26810607
[TBL] [Abstract][Full Text] [Related]
22. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
Dawood WA; Fisher GM; Kinnen FJM; Anzenhofer C; Skinner-Adams T; Alves Avelar L; Asfaha Y; Kurz T; Andrews KT
Exp Parasitol; 2024 Mar; 258():108716. PubMed ID: 38340779
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
[TBL] [Abstract][Full Text] [Related]
24. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
[TBL] [Abstract][Full Text] [Related]
25. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.
Malmquist NA; Moss TA; Mecheri S; Scherf A; Fuchter MJ
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16708-13. PubMed ID: 23011794
[TBL] [Abstract][Full Text] [Related]
26. Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents.
Vreese R; Kock C; Smith PJ; Chibale K; D'hooghe M
Future Med Chem; 2017 Mar; 9(4):357-364. PubMed ID: 28263085
[TBL] [Abstract][Full Text] [Related]
27. Flavones as isosteres of 4(1H)-quinolones: discovery of ligand efficient and dual stage antimalarial lead compounds.
Rodrigues T; Ressurreição AS; da Cruz FP; Albuquerque IS; Gut J; Carrasco MP; Gonçalves D; Guedes RC; dos Santos DJ; Mota MM; Rosenthal PJ; Moreira R; Prudêncio M; Lopes F
Eur J Med Chem; 2013 Nov; 69():872-80. PubMed ID: 24125849
[TBL] [Abstract][Full Text] [Related]
28. 4,9-Diaminoacridines and 4-Aminoacridines as Dual-Stage Antiplasmodial Hits.
Fonte M; Tassi N; Fontinha D; Bouzón-Arnáiz I; Ferraz R; Araújo MJ; Fernàndez-Busquets X; Prudêncio M; Gomes P; Teixeira C
ChemMedChem; 2021 Mar; 16(5):788-792. PubMed ID: 33217195
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel quinazoline derivatives as potent antiplasmodial agents.
Bouchut A; Rotili D; Pierrot C; Valente S; Lafitte S; Schultz J; Hoglund U; Mazzone R; Lucidi A; Fabrizi G; Pechalrieu D; Arimondo PB; Skinner-Adams TS; Chua MJ; Andrews KT; Mai A; Khalife J
Eur J Med Chem; 2019 Jan; 161():277-291. PubMed ID: 30366254
[TBL] [Abstract][Full Text] [Related]
31. Bioassay-guided isolation and characterization of active antiplasmodial compounds from Murraya koenigii extracts against Plasmodium falciparum and Plasmodium berghei.
Kamaraj C; Rahuman AA; Roopan SM; Bagavan A; Elango G; Zahir AA; Rajakumar G; Jayaseelan C; Santhoshkumar T; Marimuthu S; Kirthi AV
Parasitol Res; 2014 May; 113(5):1657-72. PubMed ID: 24638906
[TBL] [Abstract][Full Text] [Related]
32. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
Kumar A; Dhar SK; Subbarao N
J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
[TBL] [Abstract][Full Text] [Related]
33. An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation.
Hesping E; Skinner-Adams TS; Fisher GM; Kurz T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():249-256. PubMed ID: 33279862
[TBL] [Abstract][Full Text] [Related]
34. Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors.
Dow GS; Chen Y; Andrews KT; Caridha D; Gerena L; Gettayacamin M; Johnson J; Li Q; Melendez V; Obaldia N; Tran TN; Kozikowski AP
Antimicrob Agents Chemother; 2008 Oct; 52(10):3467-77. PubMed ID: 18644969
[TBL] [Abstract][Full Text] [Related]
35. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
[TBL] [Abstract][Full Text] [Related]
36. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
37. Harmicines - harmine and cinnamic acid hybrids as novel antiplasmodial hits.
Perković I; Raić-Malić S; Fontinha D; Prudêncio M; Pessanha de Carvalho L; Held J; Tandarić T; Vianello R; Zorc B; Rajić Z
Eur J Med Chem; 2020 Feb; 187():111927. PubMed ID: 31812035
[TBL] [Abstract][Full Text] [Related]
38. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.
Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y
Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472
[TBL] [Abstract][Full Text] [Related]
39. Repurposing Anticancer Drugs To Tackle Malaria.
Le Govic Y; Houzé S; Papon N
ChemMedChem; 2021 Jul; 16(14):2192-2194. PubMed ID: 33931947
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.
El-Awady R; Saleh E; Hamoudi R; Ramadan WS; Mazitschek R; Nael MA; Elokely KM; Abou-Gharbia M; Childers WE; Srinivasulu V; Aloum L; Menon V; Al-Tel TH
Bioorg Med Chem; 2021 Jul; 42():116251. PubMed ID: 34116381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
